Jul 23, 2026 07:12AM
Jul 22, 2026 08:02AM
Jul 15, 2026 07:45AM
Jun 30, 2026 08:00AM
Jun 30, 2026 06:05AM
Jun 29, 2026 07:08AM
Jun 2, 2026 06:58AM H.C. Wainwright Reiterates Buy Rating on Monopar Therapeutics (MNPR)
May 15, 2026 06:12AM
Apr 21, 2026 08:52AM
Apr 20, 2026 02:59PM
Mar 30, 2026 05:08AM
Mar 27, 2026 04:37PM
Mar 27, 2026 04:30PM
Mar 2, 2026 08:04AM Monopar appoints Susan Rodriguez as chief commercial officer
Jan 21, 2026 06:56AM
Jan 14, 2026 04:23AM
Jan 9, 2026 02:21AM
Jan 7, 2026 01:17PM
Nov 14, 2025 07:05AM
Nov 14, 2025 05:06AM
Nov 10, 2025 06:05AM Leerink Partners Starts Monopar Therapeutics (MNPR) at Outperform
Nov 10, 2025 04:52AM
Oct 13, 2025 05:30AM
Oct 10, 2025 07:24AM
Oct 6, 2025 05:31AM
Sep 29, 2025 08:05AM
Sep 25, 2025 04:35PM
Sep 25, 2025 08:07AM Monopar Therapeutics (MNPR) PT Raised to $95 at Piper Sandler
Sep 24, 2025 03:53PM
Sep 24, 2025 04:51AM
Sep 15, 2025 07:36AM
Sep 9, 2025 08:12AM
Sep 3, 2025 07:15AM
Aug 29, 2025 04:42PM
Aug 27, 2025 06:49AM Cantor Fitzgerald Reiterates Overweight Rating on Monopar Therapeutics (MNPR)
Aug 26, 2025 06:34AM
Aug 12, 2025 04:01PM
Jun 23, 2025 05:03AM
Jun 3, 2025 07:03AM
May 13, 2025 04:22PM
Apr 2, 2025 07:08AM
Mar 19, 2025 04:20AM Piper Sandler Assumes Monopar Therapeutics (MNPR) at Overweight
Jan 15, 2025 05:04PM
Jan 10, 2025 05:13AM
Dec 20, 2024 09:01AM
Nov 19, 2024 12:26PM
Nov 11, 2024 07:25AM
Nov 8, 2024 04:13PM
Oct 29, 2024 06:00AM Monopar Therapeutics (MNPR) Prices $19.2M Share Offering at $16.25/sh
Oct 28, 2024 04:00PM

422,731 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All